Chime BIologics Announces a Strategic Collaboration with MABGEEK to Accelerate the Development of Monoclonal Antibody MG-K10

Chime Biologics Successfully Passed the Pre-Approval Inspection (PAI) Conducted by the NMPA, Realizing a Leap to Commercial Manufacturing

Chime Biologics Entered into a Strategic Cooperation with JADE Biomedical to Provide International One-Stop CMC Service

Chime Biologics Announced the Expansion of GMP Manufacturing Capacity with Construction of a Second GMP Facility (GMP-2)